The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context.
about
Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial.An assessment of the measurement equivalence of English and French versions of the Center for Epidemiologic Studies Depression (CES-D) Scale in systemic sclerosis.The DiReCT study - improving recruitment into clinical trials: a mixed methods study investigating the ethical acceptability, feasibility and recruitment yield of the cohort multiple randomised controlled trials design.The comparability of English, French and Dutch scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): an assessment of differential item functioning in patients with systemic sclerosis.Exploring Sources of Emotional Distress among People Living with Scleroderma: A Focus Group StudyCohort Multiple Randomised Controlled Trials (cmRCT) design: efficient but biased? A simulation study to evaluate the feasibility of the Cluster cmRCT design.Effect of support group peer facilitator training programmes on peer facilitator and support group member outcomes: a systematic review.Evaluation of biases present in the cohort multiple randomised controlled trial design: a simulation study.The educational needs of people with systemic sclerosis: a cross-sectional study using the Dutch version of the Educational Needs Assessment Tool (D-ENAT).Translating rare-disease therapies into improved care for patients and families: what are the right outcomes, designs, and engagement approaches in health-systems research?Diagnosis and Management of Systemic Sclerosis: A Practical Approach.Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.Reasons for Not Participating in Scleroderma Patient Support Groups: A Cross-sectional Study.Emerging drugs and therapeutics for systemic sclerosis.Comparison of Self-Efficacy for Managing Chronic Disease between patients with systemic sclerosis and other chronic conditions: a systematic review.Perceived Benefits and Factors that Influence the Ability to Establish and Maintain Patient Support Groups in Rare Diseases: A Scoping Review.Understanding coping strategies among people living with scleroderma: a focus group study.Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort Study.Using Optimal Test Assembly Methods for Shortening Patient-Reported Outcome Measures: Development and Validation of the Cochin Hand Function Scale-6: A Scleroderma Patient-Centered Intervention Network Cohort Study.Commentary: considerations for using the 'Trials within Cohorts' design in a clinical trial of an investigational medicinal product.The Cohort Multiple Randomised Controlled Trial (cmRCTs) design was found to be highly susceptible to low statistical power and internal validity biases.Establishing core outcome sets for phenylketonuria (PKU) and medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys.Ethics and practice of Trials within Cohorts: An emerging pragmatic trial design.Reasons for attending support groups and organizational preferences: the European scleroderma support group members survey.Using Marital Status and Continuous Marital Satisfaction Ratings to Predict Depressive Symptoms in Married and Unmarried Women With Systemic Sclerosis: A Canadian Scleroderma Research Group Study.Challenges and proposed solutions for formative research to inform systematic intervention development in rare and unstudied conditions: The case example of Xeroderma Pigmentosum.The cohort multiple randomized controlled trial design: a valid and efficient alternative to pragmatic trials?Using a meta-narrative literature review and focus groups with key stakeholders to identify perceived challenges and solutions for generating robust evidence on the effectiveness of treatments for rare diseases.Protocol for a scoping review to support development of a CONSORT extension for randomised controlled trials using cohorts and routinely collected health dataProtocol for the development of a CONSORT extension for RCTs using cohorts and routinely collected health data
P2860
Q30842938-1B724289-3985-41FA-BB98-644B5FF1D3E4Q33921548-24BF12A3-96B7-4C38-9F61-57AC2DF18ACDQ34410706-941C3AEA-EA0B-4535-93DF-9BED5075DA16Q35123232-A1461E85-D018-4AB7-A4C2-94E029EDBD2DQ35967757-EEE3C129-7EAD-4939-ACD5-06D1F6183BE5Q36114940-A2FDFC79-5639-41CE-8A7C-39EC09FC75DDQ36195748-1D0ADFB6-D65D-4C5B-ADD3-B0503B706D82Q36265347-50969BD7-F176-4D5A-86B0-3C1DE2FDC57DQ36492239-CF4DADEC-14B9-4BBE-9A0B-36C8F29ADBE6Q38390841-71CFC121-F91B-467F-B547-9C8ACB462743Q38667111-6BC80C40-AD20-4D7B-AB14-993465B61A0DQ38826437-5A76C0D4-8E51-4184-9151-C7B069D39D76Q38952222-45DB34AE-F4FD-4144-8370-B63C60FFB366Q38998611-C5B9FF60-5EC6-4FF7-AB80-D043BB1744D6Q39014523-0D298923-723C-4DF3-901B-10E7A65C8CD9Q39048298-0D1B7002-E425-49E4-981D-870CA7C9A85AQ40079518-70B193CA-C57E-421D-B975-B46CF0029F0FQ46680373-971D8139-1861-49A9-A28E-1B354528C7D3Q46871356-2EFE75B8-D1EF-4C79-A824-44398F03126AQ47196103-69E79ECF-671E-45B4-8589-906C94D17A4BQ47249849-C886B9A9-1307-4618-BA23-E8564F426ABBQ47281654-8AF83D78-8C7D-4AA2-9E57-AA56096DA9ABQ47336289-EA967878-6B89-408D-8DED-AD63BC71B9BBQ47572961-4CD21471-F27B-4723-A0EB-7F872686AABBQ48069796-2FAED9DD-1A20-458D-B208-2506AD80DAA7Q48370959-3F8B7206-4C5B-43AA-B52B-D43BF263B48DQ52816576-29279B78-72F7-4BD9-BF02-964B212DBE2EQ55457221-0BA56F24-7437-4249-B132-BF1E9648A8FFQ57286152-F5E61EDE-F78C-4F5E-B413-C216C034D92FQ58599551-B175814C-FD34-45D9-A394-446E65065EE6
P2860
The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The Scleroderma Patient-center ...... ons in a rare disease context.
@ast
The Scleroderma Patient-center ...... ons in a rare disease context.
@en
type
label
The Scleroderma Patient-center ...... ons in a rare disease context.
@ast
The Scleroderma Patient-center ...... ons in a rare disease context.
@en
prefLabel
The Scleroderma Patient-center ...... ons in a rare disease context.
@ast
The Scleroderma Patient-center ...... ons in a rare disease context.
@en
P2093
P2860
P50
P1433
P1476
The Scleroderma Patient-center ...... ions in a rare disease context
@en
P2093
Angela Costa Maia
Ann Impens
Annett Körner
Brooke Levis
Carolyn Ells
Catarina Leite
Cindy Mendelson
Dinesh Khanna
Ilya Razykov
P2860
P356
10.1136/BMJOPEN-2013-003563
P50
P577
2013-08-07T00:00:00Z